These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 21082936)

  • 1. HIF pathway mutations and erythrocytosis.
    McMullin MF
    Expert Rev Hematol; 2010 Feb; 3(1):93-101. PubMed ID: 21082936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The HIF pathway and erythrocytosis.
    Lee FS; Percy MJ
    Annu Rev Pathol; 2011; 6():165-92. PubMed ID: 20939709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythrocytosis-associated HIF-2alpha mutations demonstrate a critical role for residues C-terminal to the hydroxylacceptor proline.
    Furlow PW; Percy MJ; Sutherland S; Bierl C; McMullin MF; Master SR; Lappin TR; Lee FS
    J Biol Chem; 2009 Apr; 284(14):9050-8. PubMed ID: 19208626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disturbance in the HIF-1alpha pathway associated with erythrocytosis: further evidences brought by frameshift and nonsense mutations in the prolyl hydroxylase domain protein 2 (PHD2) gene.
    Al-Sheikh M; Moradkhani K; Lopez M; Wajcman H; Préhu C
    Blood Cells Mol Dis; 2008; 40(2):160-5. PubMed ID: 17933562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel erythrocytosis-associated PHD2 mutation suggests the location of a HIF binding groove.
    Percy MJ; Furlow PW; Beer PA; Lappin TR; McMullin MF; Lee FS
    Blood; 2007 Sep; 110(6):2193-6. PubMed ID: 17579185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIF-1α is a protective factor in conditional PHD2-deficient mice suffering from severe HIF-2α-induced excessive erythropoiesis.
    Franke K; Kalucka J; Mamlouk S; Singh RP; Muschter A; Weidemann A; Iyengar V; Jahn S; Wieczorek K; Geiger K; Muders M; Sykes AM; Poitz DM; Ripich T; Otto T; Bergmann S; Breier G; Baretton G; Fong GH; Greaves DR; Bornstein S; Chavakis T; Fandrey J; Gassmann M; Wielockx B
    Blood; 2013 Feb; 121(8):1436-45. PubMed ID: 23264599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VHL gene methylation contributes to excessive erythrocytosis in chronic mountain sickness rat model by upregulating the HIF-2α/EPO pathway.
    Yang M; Zhu M; Song K; Wuren T; Yan J; Ge RL; Ji L; Cui S
    Life Sci; 2021 Feb; 266():118873. PubMed ID: 33309718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of oxygen-sensing pathways in physiologic and pathologic erythropoiesis.
    Semenza GL
    Blood; 2009 Sep; 114(10):2015-9. PubMed ID: 19494350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A gain-of-function mutation in the HIF2A gene in familial erythrocytosis.
    Percy MJ; Furlow PW; Lucas GS; Li X; Lappin TR; McMullin MF; Lee FS
    N Engl J Med; 2008 Jan; 358(2):162-8. PubMed ID: 18184961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on mutations in the HIF: EPO pathway and their role in erythrocytosis.
    Lappin TR; Lee FS
    Blood Rev; 2019 Sep; 37():100590. PubMed ID: 31350093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxygen sensing: recent insights from idiopathic erythrocytosis.
    Lee FS; Percy MJ; McMullin MF
    Cell Cycle; 2006 May; 5(9):941-5. PubMed ID: 16687917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythrocytosis and pulmonary hypertension in a mouse model of human HIF2A gain of function mutation.
    Tan Q; Kerestes H; Percy MJ; Pietrofesa R; Chen L; Khurana TS; Christofidou-Solomidou M; Lappin TR; Lee FS
    J Biol Chem; 2013 Jun; 288(24):17134-44. PubMed ID: 23640890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolyl hydroxylases 2 and 3 act in gliomas as protective negative feedback regulators of hypoxia-inducible factors.
    Henze AT; Riedel J; Diem T; Wenner J; Flamme I; Pouyseggur J; Plate KH; Acker T
    Cancer Res; 2010 Jan; 70(1):357-66. PubMed ID: 20028863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical characterization of human prolyl hydroxylase domain protein 2 variants associated with erythrocytosis.
    Pappalardi MB; Martin JD; Jiang Y; Burns MC; Zhao H; Ho T; Sweitzer S; Lor L; Schwartz B; Duffy K; Gontarek R; Tummino PJ; Copeland RA; Luo L
    Biochemistry; 2008 Oct; 47(43):11165-7. PubMed ID: 18834144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Congenital erythrocytosis.
    Mallik N; Das R; Malhotra P; Sharma P
    Eur J Haematol; 2021 Jul; 107(1):29-37. PubMed ID: 33840141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polycythemia and oxygen sensing.
    Maran J; Prchal J
    Pathol Biol (Paris); 2004 Jun; 52(5):280-4. PubMed ID: 15217714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel exon 12 mutations in the HIF2A gene associated with erythrocytosis.
    Percy MJ; Beer PA; Campbell G; Dekker AW; Green AR; Oscier D; Rainey MG; van Wijk R; Wood M; Lappin TR; McMullin MF; Lee FS
    Blood; 2008 Jun; 111(11):5400-2. PubMed ID: 18378852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythrocytosis associated with a novel missense mutation in the HIF2A gene.
    van Wijk R; Sutherland S; Van Wesel AC; Huizinga EG; Percy MJ; Bierings M; Lee FS
    Haematologica; 2010 May; 95(5):829-32. PubMed ID: 20007141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "Benign erythrocytosis" and other familial and congenital polycythemias.
    Prchal JT; Sokol L
    Eur J Haematol; 1996 Oct; 57(4):263-8. PubMed ID: 8982288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel biological function of soluble biglycan: Induction of erythropoietin production and polycythemia.
    Frey H; Moreth K; Hsieh LT; Zeng-Brouwers J; Rathkolb B; Fuchs H; Gailus-Durner V; Iozzo RV; de Angelis MH; Schaefer L
    Glycoconj J; 2017 Jun; 34(3):393-404. PubMed ID: 27600268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.